Journal of medical Internet research

Using Oura Ring Feedback to Help Young Adults Drink Less Alcohol: User Experience in a Small Trial

Updated

Abstract

Half of participants (30/60, 50%) were men, with a mean age of 22.02 years.

  • The overall program was described as highly acceptable, feasible, and effective by participants.
  • Wearing the Oura Ring was highly acceptable and feasible for the participants.
  • Smartphone diaries were moderately acceptable and highly effective in tracking behavior.
  • Feedback reports provided through the app were highly acceptable, feasible, and effective.
  • Participants in the feedback group showed high adherence to daily app usage, with 80% reading all feedback reports.
  • Common themes included helpfulness of the intervention components and learning about sleep deficits.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflicts of Interest: The authors attest that no external sponsors had influence on the design of this study, its outcomes, or the decision to publish. FJG is an unpaid consultant for Calm Health. KSD reports a provisional patent file for a digital system for lifestyle medicine (47162-5346-P1US), and registration of the name and content of the Call it a Night web-based sleep program with the U.S. Patent and Trademark Office (since expired). SSO reports being a member of the American Society of Clinical Psychopharmacology’s (ASCP) Alcohol Clinical Trials Initiative, supported by Alkermes, Dicerna, Eli Lilly and Company, Ethypharm, Indivior, Imbrium Therapeutics, Osuka, Pear Therapeutics, and Kinnov Therapeutics; consultant/advisory board member, Dicerna, Eli Lilly and Company, Newleos Therapeutics, University of New Mexico (NIH grant); stock options, Newleos Therapeutics; medication supplies, Novartis/Stalicla, Amygdala; contracts, Tempero Bio, Altimmune; DSMB member, Emmes Corporation, Indiana University; patent application on mavoglurant for gambling disorder with Novartis and Yale; and grants from the NIH and FDA. GIA is a scientific advisor to Behavioral Health Tech Innovations LLC. GIA receives professional services from Calm.com (nominal fee), Labfront (full fee), and GlucoseZone (full fee). GIA reports a provisional patent filed for a digital system for lifestyle medicine (047162–5346-P1US). GIA in the past 5 years has been supported by a VHA Office of Academic Affiliations Fellowship, Robert E. Leet and Clara Guthrie Patterson Trust Mentored Research Award, Bank of America, N.A., Trustee, and American Heart Association Grant #852679 (2021-2024). LMF reports grant funding from the US National Institutes of Health to directly support the research (R21AA028886), a provisional patent file for a digital system for lifestyle medicine (47162-5346-P1US), registration of the name and content of the Call it a Night web-based sleep program with the U.S. Patent and Trademark Office (since expired), and paid consultation for serving on an advisory board for Imbrium Therapeutics. All other authors report no disclosures.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free